418 related articles for article (PubMed ID: 32062360)
1. Genome-wide identification of FHL1 as a powerful prognostic candidate and potential therapeutic target in acute myeloid leukaemia.
Fu Y; Xu M; Cui Z; Yang Z; Zhang Z; Yin X; Huang X; Zhou M; Wang X; Chen C
EBioMedicine; 2020 Feb; 52():102664. PubMed ID: 32062360
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of Wnt and Fzd gene families in acute myeloid leukaemia.
Dai Y; Cheng Z; Fricke DR; Zhao H; Huang W; Zhong Q; Zhu P; Zhang W; Wu Z; Lin Q; Zhu H; Liu Y; Qian T; Fu L; Cui L; Zeng T
J Cell Mol Med; 2021 Feb; 25(3):1456-1467. PubMed ID: 33417298
[TBL] [Abstract][Full Text] [Related]
3. Construction of prognostic risk prediction model based on high-throughput sequencing expression profile data in childhood acute myeloid leukemia.
Niu P; Yao B; Wei L; Zhu H; Fang C; Zhao Y
Blood Cells Mol Dis; 2019 Jul; 77():43-50. PubMed ID: 30954792
[TBL] [Abstract][Full Text] [Related]
4. Targeting FHL1 impairs cell proliferation and differentiation of acute myeloid leukemia cells.
Liu Y; Li H; Zhao Y; Li D; Zhang Q; Fu J; Fan S
Biochem Cell Biol; 2022 Aug; 100(4):301-308. PubMed ID: 35916339
[TBL] [Abstract][Full Text] [Related]
5. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
[TBL] [Abstract][Full Text] [Related]
6. NEDD9 overexpression: Prognostic and guidance value in acute myeloid leukaemia.
Hua S; Feng T; Yin L; Wang Q; Shao X
J Cell Mol Med; 2021 Oct; 25(19):9331-9339. PubMed ID: 34432355
[TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase binding protein 1 (MAPKBP1) is an unfavorable prognostic biomarker in cytogenetically normal acute myeloid leukemia.
Fu L; Shi J; Hu K; Wang J; Wang W; Ke X
Oncotarget; 2015 Apr; 6(10):8144-54. PubMed ID: 25924238
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a 10-gene prognostic signature for acute myeloid leukaemia.
Yang Z; Shang J; Li N; Zhang L; Tang T; Tian G; Chen X
J Cell Mol Med; 2020 Apr; 24(8):4510-4523. PubMed ID: 32150667
[TBL] [Abstract][Full Text] [Related]
9. X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma.
Cao W; Liu J; Xia R; Lin L; Wang X; Xiao M; Zhang C; Li J; Ji T; Chen W
Oncotarget; 2016 Mar; 7(12):14537-50. PubMed ID: 26908444
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients.
Kayser S; Feszler M; Krzykalla J; Schick M; Kramer M; Benner A; Thol F; Platzbecker U; Müller-Tidow C; Ho AD; Ehninger G; Heuser M; Schlenk RF; Thiede C; Röllig C; Krämer A
Eur J Haematol; 2017 Dec; 99(6):544-552. PubMed ID: 28940816
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of
Cui W; Liu Y; Tan Y; Peng X; Cui L; Cheng Z; Dai Y; Fu L; Zeng T; Liu Y
Future Oncol; 2021 Feb; 17(5):541-548. PubMed ID: 33467898
[No Abstract] [Full Text] [Related]
12. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL
BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310
[TBL] [Abstract][Full Text] [Related]
13. CEBPE expression is an independent prognostic factor for acute myeloid leukemia.
Li K; Du Y; Wei DQ; Zhang F
J Transl Med; 2019 Jun; 17(1):188. PubMed ID: 31164135
[TBL] [Abstract][Full Text] [Related]
14. Weighted Gene Coexpression Network Analysis Identifies Cysteine-Rich Intestinal Protein 1 (CRIP1) as a Prognostic Gene Associated with Relapse in Patients with Acute Myeloid Leukemia.
Ye C; Ma S; Xia B; Zheng C
Med Sci Monit; 2019 Oct; 25():7396-7406. PubMed ID: 31577790
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expressions of FHL2 and iASPP predict poor prognosis in acute myeloid leukemia.
Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Zhang Z; Qin T; Hu N; Zhang Y; Ke X; Chen Y; Wu D; Shi J; Fu L
Cancer Gene Ther; 2019 Feb; 26(1-2):17-25. PubMed ID: 29910468
[TBL] [Abstract][Full Text] [Related]
16. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
[TBL] [Abstract][Full Text] [Related]
17. Lysosome-related genes predict acute myeloid leukemia prognosis and response to immunotherapy.
Wan P; Zhong L; Yu L; Shen C; Shao X; Chen S; Zhou Z; Wang M; Zhang H; Liu B
Front Immunol; 2024; 15():1384633. PubMed ID: 38799454
[TBL] [Abstract][Full Text] [Related]
18. Copy-number analysis identified new prognostic marker in acute myeloid leukemia.
Nibourel O; Guihard S; Roumier C; Pottier N; Terre C; Paquet A; Peyrouze P; Geffroy S; Quentin S; Alberdi A; Abdelali RB; Renneville A; Demay C; Celli-Lebras K; Barbry P; Quesnel B; Castaigne S; Dombret H; Soulier J; Preudhomme C; Cheok MH
Leukemia; 2017 Mar; 31(3):555-564. PubMed ID: 27686867
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia.
Park S; Kim YJ; Huh HJ; Chung HS; Lee M; Park YM; Mun YC; Seong CM; Huh J
Hematology; 2021 Dec; 26(1):904-913. PubMed ID: 34789078
[TBL] [Abstract][Full Text] [Related]
20. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
Sun GK; Tang LJ; Zhou JD; Xu ZJ; Yang L; Yuan Q; Ma JC; Liu XH; Lin J; Qian J; Yao DM
Cancer Med; 2019 Oct; 8(14):6393-6402. PubMed ID: 31486300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
